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Abstract
The APOBEC3 gene cluster encodes six cytidine deaminases (A3A-C, A3DE, A3F-H) with single stranded DNA (ssDNA)
substrate specificity. For the moment A3A is the only enzyme that can initiate catabolism of both mitochondrial and nuclear
DNA. Human A3A expression is initiated from two different methionine codons M1 or M13, both of which are in adequate
but sub-optimal Kozak environments. In the present study, we have analyzed the genetic diversity among A3A genes across
a wide range of 12 primates including New World monkeys, Old World monkeys and Hominids. Sequence variation was
observed in exons 1–4 in all primates with up to 31% overall amino acid variation. Importantly for 3 hominids codon M1 was
mutated to a threonine codon or valine codon, while for 5/12 primates strong Kozak M1 or M13 codons were found.
Positive selection was apparent along a few branches which differed compared to positive selection in the carboxy-terminal
of A3G that clusters with A3A among human cytidine deaminases. In the course of analyses, two novel non-functional A3A-
related fragments were identified on chromosome 4 and 8 kb upstream of the A3 locus. This qualitative and quantitative
variation among primate A3A genes suggest that subtle differences in function might ensue as more light is shed on this
increasingly important enzyme.
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Introduction
The APOBEC3 seven gene cluster (A3A-C, A3DE, A3F-H)
encodes six cytidine deaminases with single stranded DNA (ssDNA)
substrate specificity [1,2,3,4,5,6,7,8,9]. Several are clearly innate
restriction factors for viruses, notably for retroviruses, hepadnaviruses
or parvoviruses[3,5,6,10,11,12,13,14,15,16,17,18,19,20,21,22]. A3G
and A3F constituted such a strong barrier for the lentiviral group of
retroviruses that all but one encode a vif gene whose protein (Vif) is a
powerful antagonist [3,5,6,7,19,23,24,25,26]. Hepatitis B virus
(HBV) is restricted by at least two A3 enzymes while herpes simplex
virus type 1 is restricted by A3C [20,22,27]. To date there are no
reports of A3 antagonists encoded by these viral genomes. This
antiviral role fits with the repeated observation that several A3 genes
are up-regulated by type I and II interferons [10,28,29,30,31].
However, recent work has shown that this antiviral role is just part of
a bigger picture [30,32,33]. For example, A3A can restrict Line
transposition [11,34,35,36]. Several A3 enzymes can initiate
catabolism of mitochondrial DNA, in which uracil N-glycosylase
plays a major role downstream of editing [33]. For the moment A3A
is the only enzyme that can initiate catabolism of both mitochondrial
and nuclear DNA [33].
These A3 proteins mediate hydrolytic deamination at the C4
position that oxidises cytosine to uracil in ssDNA so generating
CRU hyper-edited molecules [1,3,5,6,7,9,22,37,38]. The active
sites of A3 enzymes are characterized by a conserved zinc-finger
HAEX23–28PCX2–4C motif [4]. These A3 enzymes show a strong
preference for cytidine deamination occurring segment carboxy-
terminal to the zinc finger impacts this dinucleotide specificity
[39]. Human A3A expression is initiated from two different
methionine codons (M1 and M13), both of which are in adequate
but sub-optimal Kozak environments [40].
Even though a number of primate genomes are available, only
the chimpanzee locus is colinear. For the orang-utan the A3A gene
is incomplete while the entire locus contains 12 exon 3/exon 6
domains rather than 11. The A3A gene is missing in the Rhesus
macaque assembly, while the marmoset locus doesn’t exist per se,
sequences being distributed over numerous contigs. As the A3
locus shows signs of extensive gene conversion, the apparent gaps
might reflect assembly problems.
We have analyzed the genetic diversity among A3A genes across
a wide range of primates including New World monkeys, Old
World monkeys and Hominids. There is variation among the
Kozak motifs with the M1 initiator methionine being absent for
chimpanzees, bonobos and gorillas. Some, but not all, A3A
lineages show positive selection suggesting that A3A enzymes may
not be truly orthologous.
Results
Primate A3A cytidine deaminases
Twelve primates A3A sequences spanning New and Old World
monkeys were derived by amplification of genomic DNA and
given aligned to the human sequence (Figure 1). The A3A protein
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proteins both with ssDNA cytidine deaminase activity [40]. The
Kozak context of both human A3A initiator codons is considered
to be adequate. For 3 hominids, codon M1 was mutated to a
threonine codon or valine codon which probably abrogates
translation initiation (Figure 1, Table 1). For both New World
monkey sequences, the M1 Kozak context was strong suggesting
that translation initiation at M13 would be reduced. In addition,
the Kozak context of the M13 codon was strong for 3/12 primates
notably C. guereza, C. aethiops and C. neglectus (Table 1). For all the
others, the context is considered to be adequate for translation
initiation.
Sequence variation was observed in all exons apart from the
very small exon 5. Some of the exon 5 sequences differ compared
to some recently reported [35]. On a pairwise basis up to 31%
amino acid divergence was observed overall, with 6%, 21% and
30% among hominids, Old World small monkeys and New World
monkeys respectively. That the variation is as great overall as that
between the New World monkeys, suggests that there has not been
too much gene conversion in the New World lineage. Exon 3
encodes the hallmark HXEX23–28PCX2–4C motif for cytidine
deaminases (Figure 1). Among all the human A3 enzymes only
A3A encodes the PCX4C variant. Interestingly, the New World
A3A sequences are singular in that they encode the PCX2C
variant typical of all other A3 enzymes.
A3A is under positive selection in Old World monkeys
In order to characterise whether this variation shows signs of
selection, we estimated the relative numbers of non-synonymous
(dN) and synonymous (dS) nucleotide substitutions per site and
dN/dS ratios over the twelve primate species using the Hyphy
Figure 1. Alignment of primate APOBEC3A proteins. Twelve primate sequences were compared to Homo sapiens used as reference. Only
differences are shown. Hyphens denote gaps introduced to maximize sequence identity. The numbering corresponds to that of the human sequence.
The letters a, b, c are added to adjacent residue to accommodate insertions. Red denotes the first (M1, exon 1) and second initiation start codons
(M13, exon 2). The crucial cytidine deaminase motif residues are highlighted in magenta. Positively and negatively selected codon sites are in blue
and green respectively. The predicted secondary structure motifs for hA3A are underlined.
doi:10.1371/journal.pone.0030036.g001
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in which the dN/dS ratio is allowed to vary among the complete
sequence using the GA-branch analysis. There was significant
positive selection with estimated dN/dS ratios .1.0 (p.0.95), at
five sites, notably D41, L62, C64, H160 & H168 (Figure 1, in
blue). By contrast, several sites were under significant negative
selection, notably S7, N24, V25c, A107, F125, E157 and W162
(Figure 1, in green).
A phylogenic tree for the complete sequence of A3A was
constructed using BioNJ (Figure 2A). The red internal branches
denote those where dN/dS.1( p .0.9) which are confined to a
small fraction of the total number of branches. Among A3
enzymes, the A3A sequence is phylogenically closest to the
carboxy-terminal domains of A3B and A3G. In view of a large
collection of A3G sequences [42], a comparable analysis was made
using the A3Gc sequences (Figure 2B). The branch-specific
patterns of dN/dS variation for both A3A and A3Gc cytidine
deaminases are different, a good example being the New World
monkey lineage.
An A3A exon 3-related sequence on human
chromosome 4
When performing Blat searches for this study (UCSC Genome
Bioinformatics), we identified a segment of 288 bp on human
Table 1. Kozak sequence contexts surrounding the A3A M1
and M13 initiation codons.
Monkey Met1
Kozak
context Met13
Kozak
context
H. sapiens CACATGG A (dequate) TTGATGG A
P. troglodytes CACACGG N(ull) TTGATGG A
P. paniscus CACACGG N TTGATGG A
G. gorilla CACGTGG N TTCATGG A
P. pygmaeus CACATGG A TTGATGG A
Hylobates lar CACATGG A TTGATGG A
C. neglectus CACATGG A GTGATGG S(trong)
C. aethiops CACATGG A GTGATGG S
C. guereza CACATGG A GTGATGG S
M. sphinx CACATGG A TTGATGG A
M. mulatta CACATGG A TTGATGG A
S. oedipus GACATGG S CTGATGG A
S. sciureus GACATGG S CTGATGG A
doi:10.1371/journal.pone.0030036.t001
Figure 2. Phylogeny of primate A3A and A3Gc cytidine deaminases. A) Neighbor-joining tree based on A3A primate sequences presented in
Figure 1. Only bootstrap values .70 are indicated. The nomenclature for the Kozak initiation sites (A: adequate, N: null, S: strong) are from Table 1. B)
Neighbor-joining tree based on A3Gc primate sequences taken in the literature. For both, red branches correspond to class dN/dS.1( p .0.9) while
the remainder correspond to classes dN/dS,1. C) The accepted divergence of the Great Apes.
doi:10.1371/journal.pone.0030036.g002
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A3Gc cluster (Figure 3A) which will be referred to as YA3chr4.
Homology went out to a few hundred bases either side with the
splice sites perfectly conserved. The sequence is present in human,
chimpanzee, gorilla, orang-utan, macaque and marmoset genomes
while absent in horse, dog, cat and rodent genomes. At the protein
level, the exon revealed a HVEXnSCX2C motif similar to that for
all A3 deaminases (HAEXnPCX2–4C) (Figure 3A). While the
ARV substitution is found in AID and APOBEC1 sequences, the
PRS substitution is without precedent. Phylogenic analysis based
on amino acid sequences showed that it emerged after the (A3A,
A3Bc)A3Gc split (Figure 3B).
59 and 39 RACE failed to identify any transcripts while no EST
was found in the databases. Nonetheless, to ascertain whether this
exon encoded a functional domain, we synthesized a fusion gene
with the exon surrounded by exons 1, 2, 4 and 5 of the human A3A
gene. The construct was cloned in pcDNA3.1 TOPO resulting in
addition of the V5 tag. When transfected into HeLa cells and
stained with FITC-conjugated anti-V5 antibody the construct was
viable and strongly nuclear, more so than hA3A indicating that
residues impacting A3A localization lie in exon 3 (Figure 3C). In
order to demonstrate editing activity, HeLa cells were co-
transfected by the reconstructed pYA3chr4 clone and an
infectious molecular clone of hepatitis B virus. Total DNA was
analysed at 72 hrs by a nested PCR/3DPCR approach as
previously described [22,43].
The minimal denaturation temperature (Td) for the HBV X
gene segment analysed is 91.8uC (Figure 3D, [22]). When co-
transfected with the reconstructed pYA3chr4 clone, the lowest Td
was equally 91.8uC indicating that the recombinant may not be
packaged into assembling HBV virions. Accordingly, a non-viral
region corresponding to MT-COI gene was been amplified by
PCR/3DPCR [33]. The minimal Td for MT-COI DNA was 87uC
with or without pYA3chr4 (Figure 3E), suggesting that the
chromosome 4 fragment is indeed devoid of ssDNA cytidine
deaminase activity.
Finally, an additional ,1.1 kb A3A-related fragment was
identified ,8 kb upstream of the human A3A gene in the same
orientation as the entire A3 locus. For comparison, the A3A-A3B
intergenic region is ,19 kb. The fragment comprises 104 bp
(37%) of intron 4, exon 5 and downstream sequences. Overall it
shows 96% nucleic acid homology to hA3A. As such it must
Figure 3. No cytidine deaminase activity associated with pYA3chr4. A) Alignment of exon 3 of YA3chr4 proteins to human A3Bc, A3Gc and
A3A. Differences with respect to YA3chr4 are highlighted in red. B) Neighbor-joining tree based on the exon 3 of human A3 genes. Only bootstrap
values of .70 are given. C) Immunostaining of the V5-tagged pYA3chr4 and A3A proteins with DAPI nuclear counterstain. D) Agarose gel of 3DPCR
products across a denaturation temperature gradient from 93 to 85uC of X region of HBV. pCayw is an infectious molecular clone along with the
empty expression vector, along with pYA3chr4. M; molecular weight markers. The white asterisks denote the last amplification product obtained at
91.8uC. E) Agarose gel of 3DPCR products across a denaturation temperature gradient from 89 to 79uCo nMT-COI gene. The white asterisks denote
the last amplification product of MT-COI obtained at 87uC.
doi:10.1371/journal.pone.0030036.g003
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is surrounded by repeat elements, some of which are found
surrounding the hA3A and hA3B genes. This A3A remnant is found
in the chimpanzee, orang-utan and rhesus macaque genomes.
Discussion
The primate A3A gene shows considerable qualitative and
quantitative genetic variation, with up to 31% amino acid
variation. Translation initiation sites vary there being at least four
different configurations (Table 1). Positive selection is apparent
along a few but not all branches suggesting that differences may
emerge when more attention is turned to this important enzyme.
From the outset, differences in the restriction patterns of
primate A3G on HIV-1Dvif were noted [44,45,46]. More recent
reports show that several human and macaque A3 cytidine
deaminases are not strictly equivalent when using HIV-1 as a
readout [47]. Indeed, as several reports have shown subtle
differences for A3B, A3DE and A3G [47,48,49], this should
transpire for A3A. However, as this enzyme impacts the integrity
of the human genome, it is possible that the variation in structure
and evolution of the A3A gene could impact cell biology.
During data analyses, two A3A related fragments were
identified. The YA3chr4 exon 3 fragment proved to be devoid
of catalytic activity when spliced together with exons 1, 2, 4 and 5
from A3A. This solo A3 exon is reminiscent of the recent finding of
an isolated APOBEC1 exon in the tetrapod lineage that was
subsequently lost [50]. The second A3A fragment is particularly
interesting in that it shows that the present organization of the
primate A3 locus might well have come about via more gene
conversion than previously thought [51]. In conclusion, there is
subtle qualitative and quantitative variation among primate A3A
genes. In turn, gene expression and perhaps interferon sensitivity
might follow.
Materials and Methods
Animal samples
Faecal samples were collected from wild non-habituated
western gorilla (Gorilla gorilla gorilla) and chimpanzees (Pan troglodytes
troglodytes) in Cameroun with permission of the Cameroonian
Ministries of Health, Research and Environment and Forestry and
Wildlife, and from bonobo (Pan paniscus) in the Democratic
Republic of Congo with the permission of the Ministries of Science
and Technology and Forest Economy [52]. DNA was extracted as
previously described [53]. For mantled guereza (Colobus guereza)
and mandrills (Mandrillus sphinx), DNA was extracted from whole
blood on samples that were collected on primate bushmeat with
permission from Cameroonian Ministries of Health, Research and
Environment and Forestry and Wildlife, as previously reported
[54]. Primary cells and cells line were obtained for orang-utan
(Pongo pygmaeus) that died of natural causes while housed at the
Wanariset orang-utan Reintroduction Center in East Kalimantan,
Indonesia [55] and white-handed gibbon (Hylobates lar, ATCC
57763) respectively, while samples of rhesus monkey (Macaca
mulatta, ATCC CCL-7), vervet monkey (Cercopithecus aethiops,
ATCC CCL-81), and necropsy tissue samples from a squirrel
monkey (Saimiri sciureus) and cotton-top tamarin (Sanguinus Oedipus)
that died of natural causes while kept in a zoo have been already
described [56]. Primary cells from De Brazza’s monkey (Cercopi-
thecus neglectus) came from an animal that died of natural causes
while housed at the zoo de la Palmyre (France).
PCR amplification, cloning and sequencing
Hot start PCR was performed with corresponding primers
(Table 2). The first reaction involved standard amplification, the
reaction parameters were 95uC for 5 min., followed by 35 cycles
(95uC for 30 s., 50–55uC for 30 s. and 72uC for 1 min.) and finally
for 10 min. at 72uC for the first round. Differential amplification
occurred in the second round using the equivalent of 0.2 mL of the
first round reaction as input. Conditions were identical to the first
PCR. The buffer conditions for all amplification were 2.5 mM
MgCl2, 50 mM KCl, 10 mM Tris-HCl pH 8.3, 200 mM of each
dNTP, 100 mM of each primer, and 2.5 units of BIOTaq
polymerase (Bioline) in a final volume of 50 mL. PCR products
were purified from agarose gels (Qiaex II kit, Qiagen, France) and
ligated into the TOPO TA cloning vector (Invitrogen, France).
After transformation of Top10 electrocompetent cells (Invitrogen),
up to 15 clones were picked. Sequencing was outsourced to GATC
biotech. All mutations were confirmed by inspection of the
chromatogram. The pYA3chr4 insert was synthetized by
GeneCust and cloned into the pcDNA3.1 TOPO-V5 vector
(Invitrogen).
Cells and transfections
Briefly, 10
5 QT6 cells (ATCC CRL 1708) were cotransfected
with 1 mgo fp YA3chr4 plasmid DNA along with 1 mg pCayw, a
plasmid encoding an infectious molecular genome of hepatitis B
virus (HBV) using FuGENE 6 (Roche). Total DNA was extracted
using the MasterPureTM complete DNA and RNA purification
kit (Epicentre). QT6 cells were maintained in HAM’s F40
medium, supplemented with 1% chicken serum, 10% FCS, 5%
tryptose phosphate, 2 mM L-glutamine, 50 U/ml penicillin and
50 mg/ml streptomycin [15].
Immunofluorescence
HeLa cells (ATCC CCL 2) were grown to a density of 5.10
5
cells per dish [15] and transfected with 1 mgo fp YA3chr4 or
Table 2. Compendium of all PCR primers used in the study.
Primer Sequence
E1out5 59 AGAACTTCCTTGTTCTGATGCTAATGTGGGTGG
E1out3 59AAAGGGAGGCCCCGGGGTTTGAGGGTGA
E1int5 59 GGCCTGAGCTGGAGAAGGGGTGGGGCAG
E1int3 59 TCAGAAAAGCTCAAAGAGGAGGCTGAGG
E2out5 59 GGCCTGAGCACACTGAGCTGACCCTGGG
E2out3 59 GAATGTCCCTGGAYTGGRAGGGCCCTG
E2int5 59 GAGACCCTGACAAGGCTTAGACA
E3out5 59 TGGTCCAGGCCCTCCCTCCCTGTTCAC
E3out3 59 CARGCARCAGMCCAAGGCCTTTCTCC
E3int5 59 ACCTCACACTCTGTTTCCTTTTCTA
E3int3 59 CCCACCCCACCCCACCTGAACCTTCC
E4out5 59 CGGGARYGKGACTTATCTCYCCTGTC
E4out3 59 GGAGGWGGCCTGGGGACAGKGACAATGA
E4int3 59 GGGAGAAGGAGGGAGGGATGCGGGAGG
E5out5 59 TGTGCCCTCTTTCCACTCTCTCACCTCC
E5out3 59 TCTGCTGCTCAACCCAGGTCTCT
E5int5 59 CCACTCTCTCACCTCCTGCTCCA
E5int3 59 TCTCTGCCTTCCTTAGAGACTGA
doi:10.1371/journal.pone.0030036.t002
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washed twice with PBS, fixed for 45 minutes in a 50:50 methanol/
ethanol mix. As primary antibodies, a mouse monoclonal antibody
specific for the V5 epitope tag (Invitrogen) was used at a 1:200
dilution for 1 hour at room temperature. Cells were washed twice
with PBS, and FITC-conjugated anti-mouse antibody anti-mouse
was used as second antibody (Sigma) at a dilution 1:200 for
30 minutes at room temperature. We used Vectashield, mounting
medium for fluorescence with DAPI (Vector laboratories, Inc.).
Immunofluorescence was observed by microscopy (Zeiss).
Phylogenic and computational analyses
Sequences were aligned using the MUSCLE program, and
neighbor-joining trees were obtained using BioNJ as implemented
in http://phylogeny.fr. The final output was edited using Tree-
view [57]. The relative numbers of non-synonymous (dN) and
synonymous (dS) nucleotide substitutions per site were estimated
using the random effects likelihood (REL) and the fixed effects
likelihood (FEL) methods available via the Datamonkey web
interface of the HyPhy package [58]. Estimates of dN/dS ratios
were based on neighbor-joining trees obtained from phylogeny.fr.
We used the genetic algorithm (GA-Branch) method available
in HyPhy [58] to detect lineage-specific variation in selection
pressure. This assigns different classes of dN/dS ratios to each
lineage to determine the best-fit model of lineage-specific
evolution, and it calculates the probability ($90%) that along a
specific lineage dN/dS.1 [41].
Accession numbers were deposited at GenBank: Colobus guereza
(JN177339), Cercopithecus aethiops (JN177340), Cercopithecus neglectus
(JN177341), Mandrillus sphinx (JN177342), Macaca mulatta
(JN177343), Hylobates lar (JN177344), Gorilla gorilla (JN177345),
Pongo pygmaeus (JN177346), Pan paniscus (JN177347), Pan troglodytes
troglodytes (JN177348), Saguinus oedipus (JN177349) and Saimiri
sciureus (JN177350).
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